Obicetrapib sodium

SI-6778

Obicetrapib sodium, >98% (HPLC)

CAS No. : [866399-88-4]

Synonyms : TA-8995 sodium; DEZ-001 sodium; AMG-899 sodium

IUPAC Name : Sodium 4-((2-((3,5-bis(trifluoromethyl)benzyl)((2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)amino)pyrimidin-5-yl)oxy)butanoate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Obicetrapib sodium is an orally active CETP inhibitor that robustly decreases LDL‑C, ApoB, and Lp(a) and increases HDL‑C. Its lipid‑modulating profile makes it a valuable tool for investigating dyslipidemia and ASCVD mechanisms.

References : Kastelein J. J. P. et al.: Curr. Atheroscler. Rep., 26(2), 35-44, 2024.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.